SF3B1
Splicing factor 3B subunit 1
Also known as: Hsh155, Prp10, PRPF10, SAP155, SF3B1_HUMAN, SF3b155
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75533
- Gene
- SF3B1
- Ensembl
- ENSG00000115524
- Chromosome
- 2
- Canonical length
- 1304 aa
- Protein class
- Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
This gene encodes subunit 1 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. The carboxy-terminal two-thirds of subunit 1 have 22 non-identical, tandem HEAT repeats that form rod-like, helical structures. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1304 residues, UniProt reviewed canonical sequence.
>O75533|SF3B1
1 MAKIAKTHED IEAQIREIQG KKAALDEAQG VGLDSTGYYD QEIYGGSDSR FAGYVTSIAA
61 TELEDDDDDY SSSTSLLGQK KPGYHAPVAL LNDIPQSTEQ YDPFAEHRPP KIADREDEYK
121 KHRRTMIISP ERLDPFADGG KTPDPKMNAR TYMDVMREQH LTKEEREIRQ QLAEKAKAGE
181 LKVVNGAAAS QPPSKRKRRW DQTADQTPGA TPKKLSSWDQ AETPGHTPSL RWDETPGRAK
241 GSETPGATPG SKIWDPTPSH TPAGAATPGR GDTPGHATPG HGGATSSARK NRWDETPKTE
301 RDTPGHGSGW AETPRTDRGG DSIGETPTPG ASKRKSRWDE TPASQMGGST PVLTPGKTPI
361 GTPAMNMATP TPGHIMSMTP EQLQAWRWER EIDERNRPLS DEELDAMFPE GYKVLPPPAG
421 YVPIRTPARK LTATPTPLGG MTGFHMQTED RTMKSVNDQP SGNLPFLKPD DIQYFDKLLV
481 DVDESTLSPE EQKERKIMKL LLKIKNGTPP MRKAALRQIT DKAREFGAGP LFNQILPLLM
541 SPTLEDQERH LLVKVIDRIL YKLDDLVRPY VHKILVVIEP LLIDEDYYAR VEGREIISNL
601 AKAAGLATMI STMRPDIDNM DEYVRNTTAR AFAVVASALG IPSLLPFLKA VCKSKKSWQA
661 RHTGIKIVQQ IAILMGCAIL PHLRSLVEII EHGLVDEQQK VRTISALAIA ALAEAATPYG
721 IESFDSVLKP LWKGIRQHRG KGLAAFLKAI GYLIPLMDAE YANYYTREVM LILIREFQSP
781 DEEMKKIVLK VVKQCCGTDG VEANYIKTEI LPPFFKHFWQ HRMALDRRNY RQLVDTTVEL
841 ANKVGAAEII SRIVDDLKDE AEQYRKMVME TIEKIMGNLG AADIDHKLEE QLIDGILYAF
901 QEQTTEDSVM LNGFGTVVNA LGKRVKPYLP QICGTVLWRL NNKSAKVRQQ AADLISRTAV
961 VMKTCQEEKL MGHLGVVLYE YLGEEYPEVL GSILGALKAI VNVIGMHKMT PPIKDLLPRL
1021 TPILKNRHEK VQENCIDLVG RIADRGAEYV SAREWMRICF ELLELLKAHK KAIRRATVNT
1081 FGYIAKAIGP HDVLATLLNN LKVQERQNRV CTTVAIAIVA ETCSPFTVLP ALMNEYRVPE
1141 LNVQNGVLKS LSFLFEYIGE MGKDYIYAVT PLLEDALMDR DLVHRQTASA VVQHMSLGVY
1201 GFGCEDSLNH LLNYVWPNVF ETSPHVIQAV MGALEGLRVA IGPCRMLQYC LQGLFHPARK
1261 VRDVYWKIYN SIYIGSQDAL IAHYPRIYND DKNTYIRYEL DYILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SF3B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 288 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 288 nTPM
- spleen: 230 nTPM
- thymus: 207 nTPM
- lymph node: 190 nTPM
- epididymis: 189 nTPM
- tonsil: 187 nTPM
Single-cell type
- neutrophils: 495 nCPM
- neutrophil progenitors: 284 nCPM
- monocyte progenitors: 250 nCPM
- monocytes: 246 nCPM
- erythrocyte progenitors: 226 nCPM
- innate lymphoid cells: 208 nCPM
Immune cell
- T-reg: 72 nTPM
- neutrophil: 61 nTPM
- myeloid DC: 61 nTPM
- eosinophil: 58 nTPM
- NK-cell: 57 nTPM
- total PBMC: 56 nTPM
Brain region
- choroid plexus: 173 nTPM
- white matter: 162 nTPM
- cerebellum: 136 nTPM
- basal ganglia: 118 nTPM
- medulla oblongata: 117 nTPM
- spinal cord: 110 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SF3B1.
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 98 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.07
- gnomAD pLI
- 1
- gnomAD missense Z
- 7.7
- DepMap mean gene effect
- -1.5
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- mRNA splicing, via spliceosome
- positive regulation of transcription by RNA polymerase I
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase III
- RNA splicing
- RNA splicing, via transesterification reactions
- spliceosomal complex assembly
- U2-type prespliceosome assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-like helical
- Armadillo-type fold
- Phosphatase PP2A regulatory subunit A/Splicing factor 3B subunit 1-like, HEAT repeat
- PPP2R1A-like HEAT repeat
- Splicing factor 3B subunit 1
- Splicing factor 3B subunit 1-like
- Splicing factor 3B subunit 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SF3B1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SF3B1 as an antibody target. Whether an autoantibody or antibody against SF3B1 could matter depends on whether native SF3B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SF3B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SF3B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...